Characterization of adverse reactions to four common targeted drugs for hepatocellular carcinoma in WHO-VigiAccess
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality, with limited therapeutic options available for advanced stages of the disease. Treatment strategies for HCC are multimodal and largely depend on the disease stage, liver function, and individual patient...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2025-05-01
|
| Серии: | Scientific Reports |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1038/s41598-025-00004-7 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|